Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Melamax® protects skin from UV damage and reduces inflammation and oxidative stress.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Methotrexate plus prednisolone had the fewest serious side effects.

The new minoxidil gel may improve hair loss treatment by staying on the scalp longer and penetrating better.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Newly made nicotinamide compounds could potentially treat cancer.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

The drug combination was safe and showed promise in treating advanced tumors.

Minoxidil can cause unexpected heart problems like chest pain.

The method produces finasteride with a 92% yield.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Merck will refund the cost of the drug finasteride if it doesn't improve symptoms within six months or if the patient needs surgery within two years.

The new formulation improved the skin absorption of the drug Thiocolchicoside.